Akèy › Poliradikiloneyropati demyelinizan enflamatwa kwonik
Etid klinik pou Poliradikiloneyropati demyelinizan enflamatwa kwonik ap rekrite nan Etazini
19 etid pou Poliradikiloneyropati demyelinizan enflamatwa kwonik ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY7 etid
- Miami, FL6 etid
- Houston, TX6 etid
- Philadelphia, PA5 etid
- Kansas City, KS5 etid
- New Haven, CT5 etid
- Indio, CA5 etid
- St. Louis, MO5 etid
- Washington, DC4 etid
- Orlando, FL4 etid
- San Francisco, CA4 etid
- Milwaukee, WI4 etid
- Birmingham, AL4 etid
- Cleveland, OH4 etid
- Tampa, FL4 etid
- Portland, OR3 etid
- Boston, MA3 etid
- Centennial, CO3 etid
- Austin, TX3 etid
- Cincinnati, OH3 etid
- Scottsdale, AZ3 etid
- Seattle, WA3 etid
Pa eta
- Alabama4 etid
- Arizona4 etid
- Colorado5 etid
- Connecticut6 etid
- Distrik Columbia4 etid
- Florid11 etid
- Illinois4 etid
- Kalifòni11 etid
- Kansas5 etid
- Lwizyàn3 etid
- Maryland3 etid
- Massachusetts4 etid
- Michigan5 etid
- Missouri5 etid
- New York8 etid
- North Carolina6 etid
- Ohio7 etid
- Oregon3 etid
- Pennsylvania6 etid
- Tennessee3 etid
- Texas10 etid
- Washington3 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07032662Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05327114A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07091630A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06920004A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06290141A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY) in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06752356A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07540221A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06858579A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Aug 14, 2026 · NCT07304154Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06968975Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07264426A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT06798012Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 17, 2026 · NCT07478172A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Feb 17, 2026 · NCT06299748A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT06747351IVIG vs SCIG in CIDP
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Dec 11, 2025 · NCT05584631A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT06538064Biorepository and Registry for Plasma Exchange Patients
Ap rekriteEtid obsèvasyon
Laj 12 a 99 · Tout sèks · Mizajou May 20, 2025 · NCT05004493Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.